Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 120

1.

Measuring nitrate reductase activity from human and rodent tongues.

Ahmed KA, Nichols AL, Honavar J, Dransfield MT, Matalon S, Patel RP.

Nitric Oxide. 2017 Jun 1;66:62-70. doi: 10.1016/j.niox.2017.04.001. Epub 2017 Apr 5.

PMID:
28390999
2.

Gender differences in first and secondhand smoke exposure, spirometric lung function and cardiometabolic health in the old order Amish: A novel population without female smoking.

Reed RM, Dransfield MT, Eberlein M, Miller M, Netzer G, Pavlovich M, Pollin TI, Scharf SM, Shuldiner AR, Sin D, Mitchell BD.

PLoS One. 2017 Mar 31;12(3):e0174354. doi: 10.1371/journal.pone.0174354. eCollection 2017.

PMID:
28362870
3.

Association Between Cardiorespiratory Fitness and Lung Health from Young Adulthood to Middle Age.

Benck LR, Cuttica MJ, Colangelo LA, Sidney S, Dransfield MT, Mannino DM, Jacobs DR Jr, Lewis CE, Zhu N, Washko GR, Liu K, Carnethon MR, Kalhan R.

Am J Respir Crit Care Med. 2017 Mar 1. doi: 10.1164/rccm.201610-2089OC. [Epub ahead of print]

PMID:
28248551
4.

GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.

Martinez CH, Freeman CM, Nelson JD, Murray S, Wang X, Budoff MJ, Dransfield MT, Hokanson JE, Kazerooni EA, Kinney GL, Regan EA, Wells JM, Martinez FJ, Han MK, Curtis JL; COPDGene Investigators..

Respir Res. 2017 Feb 28;18(1):42. doi: 10.1186/s12931-017-0521-1.

PMID:
28245821
5.

Ventricular Geometry From Non-contrast Non-ECG-gated CT Scans: An Imaging Marker of Cardiopulmonary Disease in Smokers.

Rahaghi FN, Vegas-Sanchez-Ferrero G, Minhas JK, Come CE, De La Bruere I, Wells JM, González G, Bhatt SP, Fenster BE, Diaz AA, Kohli P, Ross JC, Lynch DA, Dransfield MT, Bowler RP, Ledesma-Carbayo MJ, San José Estépar R, Washko GR; COPDGene Investigators..

Acad Radiol. 2017 Feb 15. pii: S1076-6332(17)30008-9. doi: 10.1016/j.acra.2016.12.007. [Epub ahead of print]

PMID:
28215632
6.

A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.

Bhatt SP, Dransfield MT, Cockcroft JR, Wang-Jairaj J, Midwinter DA, Rubin DB, Scott-Wilson CA, Crim C.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 19;12:351-365. doi: 10.2147/COPD.S117373. eCollection 2017.

PMID:
28176907
7.

Biomechanical CT metrics are associated with patient outcomes in COPD.

Bodduluri S, Bhatt SP, Hoffman EA, Newell JD Jr, Martinez CH, Dransfield MT, Han MK, Reinhardt JM; COPDGene Investigators..

Thorax. 2017 May;72(5):409-414. doi: 10.1136/thoraxjnl-2016-209544. Epub 2017 Jan 2.

PMID:
28044005
8.

Results of a Medicare Bundled Payments for Care Improvement Initiative for COPD Readmissions.

Bhatt SP, Wells JM, Iyer AS, Kirkpatrick DP, Parekh TM, Leach LT, Anderson EM, Sanders JG, Nichols JK, Blackburn CC, Dransfield MT.

Ann Am Thorac Soc. 2016 Dec 22. doi: 10.1513/AnnalsATS.201610-775BC. [Epub ahead of print]

PMID:
28005410
9.

Lung Mass in Smokers.

Washko GR, Kinney GL, Ross JC, San José Estépar R, Han MK, Dransfield MT, Kim V, Hatabu H, Come CE, Bowler RP, Silverman EK, Crapo J, Lynch DA, Hokanson J, Diaz AA; COPDGene Investigators..

Acad Radiol. 2017 Apr;24(4):386-392. doi: 10.1016/j.acra.2016.10.011. Epub 2016 Dec 8.

PMID:
27940230
10.

Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study.

Wells JM, Estepar RS, McDonald MN, Bhatt SP, Diaz AA, Bailey WC, Jacobson FL, Dransfield MT, Washko GR, Make BJ, Casaburi R, van Beek EJ, Hoffman EA, Sciurba FC, Crapo JD, Silverman EK, Hersh CP; COPDGene Investigators..

BMC Pulm Med. 2016 Dec 1;16(1):169.

PMID:
27903260
11.

Pulmonary Rehabilitation Improves Outcomes in Chronic Obstructive Pulmonary Disease Independent of Disease Burden.

Schroff P, Hitchcock J, Schumann C, Wells JM, Dransfield MT, Bhatt SP.

Ann Am Thorac Soc. 2017 Jan;14(1):26-32. doi: 10.1513/AnnalsATS.201607-551OC.

PMID:
27739881
12.

A ferret model of COPD-related chronic bronchitis.

Raju SV, Kim H, Byzek SA, Tang LP, Trombley JE, Jackson P, Rasmussen L, Wells JM, Libby EF, Dohm E, Winter L, Samuel SL, Zinn KR, Blalock JE, Schoeb TR, Dransfield MT, Rowe SM.

JCI Insight. 2016 Sep 22;1(15):e87536.

PMID:
27699245
13.

Arterial and Venous Pulmonary Vascular Morphology and Their Relationship to Findings in Cardiac Magnetic Resonance Imaging in Smokers.

Rahaghi FN, Wells JM, Come CE, De La Bruere IA, Bhatt SP, Ross JC, Vegas-Sánchez-Ferrero G, Diaz AA, Minhas J, Dransfield MT, San José Estépar R, Washko GR; and the COPDGene Investigators..

J Comput Assist Tomogr. 2016 Nov/Dec;40(6):948-952.

PMID:
27636250
14.

Cardiovascular disease in COPD: time to quash a silent killer.

Bolton CE, Quint JK, Dransfield MT.

Lancet Respir Med. 2016 Sep;4(9):687-9. doi: 10.1016/S2213-2600(16)30243-0. No abstract available.

PMID:
27599243
15.

Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.

Dransfield MT, Kunisaki KM, Strand MJ, Anzueto A, Bhatt SP, Bowler RP, Criner GJ, Curtis JL, Hanania NA, Nath H, Putcha N, Roark SE, Wan ES, Washko GR, Wells JM, Wendt CH, Make BJ; COPDGene Investigators..

Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.

PMID:
27556408
16.

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol.

Pascoe SJ, Lipson DA, Locantore N, Barnacle H, Brealey N, Mohindra R, Dransfield MT, Pavord I, Barnes N.

Eur Respir J. 2016 Aug;48(2):320-30. doi: 10.1183/13993003.02165-2015. Epub 2016 Jul 13.

PMID:
27418551
17.

Beta-blockers in COPD: time for reappraisal.

Lipworth B, Wedzicha J, Devereux G, Vestbo J, Dransfield MT.

Eur Respir J. 2016 Sep;48(3):880-8. doi: 10.1183/13993003.01847-2015. Epub 2016 Jul 7. Review.

PMID:
27390282
18.

Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.

Wells JM, Farris RF, Gosdin TA, Dransfield MT, Wood ME, Bell SC, Rowe SM.

Lancet Respir Med. 2016 Aug;4(8):636-45. doi: 10.1016/S2213-2600(16)30105-9. Epub 2016 Jun 10.

PMID:
27298019
19.

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.

Bhatt SP, Connett JE, Voelker H, Lindberg SM, Westfall E, Wells JM, Lazarus SC, Criner GJ, Dransfield MT.

BMJ Open. 2016 Jun 7;6(6):e012292. doi: 10.1136/bmjopen-2016-012292.

PMID:
27267111
20.

Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective.

Han MK, Martinez CH, Au DH, Bourbeau J, Boyd CM, Branson R, Criner GJ, Kalhan R, Kallstrom TJ, King A, Krishnan JA, Lareau SC, Lee TA, Lindell K, Mannino DM, Martinez FJ, Meldrum C, Press VG, Thomashow B, Tycon L, Sullivan JL, Walsh J, Wilson KC, Wright J, Yawn B, Zueger PM, Bhatt SP, Dransfield MT.

Lancet Respir Med. 2016 Jun;4(6):473-526. doi: 10.1016/S2213-2600(16)00094-1. Epub 2016 May 13. Review.

PMID:
27185520

Supplemental Content

Loading ...
Support Center